Search

Your search keyword '"Weil, Joachim"' showing total 394 results

Search Constraints

Start Over You searched for: Author "Weil, Joachim" Remove constraint Author: "Weil, Joachim"
394 results on '"Weil, Joachim"'

Search Results

4. Kommentar zum Konsensuspapier zur renalen Denervation der Arbeitsgruppe Hypertonie der European Society of Cardiology (ESC) und der European Association of Percutaneous Cardiovascular Interventions (EAPCI)

5. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

6. Arterielle Hypertonie

7. Herzerkrankungen

9. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

13. Arterielle Hypertonie

14. Herzerkrankungen

15. Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range

16. Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis.

18. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

19. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), der Deutschen Hochdruckliga e. V. DHL®/Deutschen Gesellschaft für Hypertonie und Prävention und der Deutschen Gesellschaft für Nephrologie (DGfN) zur Zertifizierung von „Renale-Denervations-Zentren (RDZ)“ – Update

20. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

21. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

22. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

23. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

24. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

26. Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE

39. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

40. Long-term efficacy and safety of renal denervation: an update from registries and randomised trials.

41. Prolonged Door-to-Balloon Time Leads to Endothelial Glycocalyx Damage and Endothelial Dysfunction in Patients with ST-Elevation Myocardial Infarction.

44. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation

47. Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension – WAVE IV

Catalog

Books, media, physical & digital resources